Literature DB >> 15647428

Circadian melatonin and cortisol levels in rheumatoid arthritis patients in winter time: a north and south Europe comparison.

M Cutolo1, G J M Maestroni, K Otsa, O Aakre, B Villaggio, S Capellino, P Montagna, L Fazzuoli, T Veldi, T Peets, E Hertens, A Sulli.   

Abstract

BACKGROUND: Altered functioning of the hypothalamic-pituitary-adrenal axis and altered melatonin production might modulate the circadian symptoms in patients with rheumatoid arthritis.
OBJECTIVE: To investigate the influence of different winter photoperiods on the circadian rhythms of serum melatonin, cortisol, tumour necrosis factor alpha (TNFalpha), and interleukin 6 (IL6) in patients with rheumatoid arthritis from a north Europe country (Estonia) and a south Europe country (Italy).
METHODS: The patients from Estonia (n = 19) and Italy (n = 7) had similar disease severity and duration and were compared with healthy age and sex matched controls in the two countries. Blood samples were collected during the period January to February at 8 pm, 10 pm, midnight, 2 am, 4 am, 6 am, 8 am, and 3 pm. Melatonin was measured by radioimmunoassay using (125)I-melatonin. Serum cortisol, TNFalpha, and IL6 cytokines were assayed by standard methods.
RESULTS: Higher circadian melatonin concentrations from 10 pm and an earlier peak were observed in Estonian patients than in their age and sex matched controls (p<0.01). Starting from midnight, melatonin concentrations were significantly higher in the Estonian patients than in the Italian patients. No significant differences were observed for serum cortisol. Serum TNFalpha was higher (p<0.05) in Estonian patients than in their controls and was correlated with the melatonin levels.
CONCLUSIONS: In a north European country (Estonia), the circadian rhythm of serum concentrations of melatonin and TNFalpha in patients with rheumatoid arthritis were significantly higher than in matched controls or in rheumatoid patients from a south Europe country (Italy).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15647428      PMCID: PMC1755372          DOI: 10.1136/ard.2004.023416

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  32 in total

1.  Diurnal rhythm of salivary cortisol levels in patients with recent-onset rheumatoid arthritis.

Authors:  J C Dekkers; R Geenen; G L Godaert; L J van Doornen; J W Bijlsma
Journal:  Arthritis Rheum       Date:  2000-02

2.  Evidence for melatonin synthesis in mouse and human bone marrow cells.

Authors:  A Conti; S Conconi; E Hertens; K Skwarlo-Sonta; M Markowska; J M Maestroni
Journal:  J Pineal Res       Date:  2000-05       Impact factor: 13.007

Review 3.  Hypothalamic-pituitary-adrenal-glucocorticoid axis function in rheumatoid arthritis.

Authors:  A T Masi; G P Chrousos
Journal:  J Rheumatol       Date:  1996-04       Impact factor: 4.666

4.  Transition from dim to bright light in the morning induces an immediate elevation of cortisol levels.

Authors:  R Leproult; E F Colecchia; M L'Hermite-Balériaux; E Van Cauter
Journal:  J Clin Endocrinol Metab       Date:  2001-01       Impact factor: 5.958

5.  Melatonin enhances IL-2, IL-6, and IFN-gamma production by human circulating CD4+ cells: a possible nuclear receptor-mediated mechanism involving T helper type 1 lymphocytes and monocytes.

Authors:  S Garcia-Mauriño; M G Gonzalez-Haba; J R Calvo; M Rafii-El-Idrissi; V Sanchez-Margalet; R Goberna; J M Guerrero
Journal:  J Immunol       Date:  1997-07-15       Impact factor: 5.422

Review 6.  The immunotherapeutic potential of melatonin.

Authors:  G J Maestroni
Journal:  Expert Opin Investig Drugs       Date:  2001-03       Impact factor: 6.206

Review 7.  Involvement of the hypothalamic--pituitary--adrenal/gonadal axis and the peripheral nervous system in rheumatoid arthritis: viewpoint based on a systemic pathogenetic role.

Authors:  R H Straub; M Cutolo
Journal:  Arthritis Rheum       Date:  2001-03

8.  Melatonin influences interleukin-12 and nitric oxide production by primary cultures of rheumatoid synovial macrophages and THP-1 cells.

Authors:  M Cutolo; B Villaggio; F Candido; S Valenti; M Giusti; L Felli; A Sulli; S Accardo
Journal:  Ann N Y Acad Sci       Date:  1999-06-22       Impact factor: 5.691

Review 9.  Vitamin D and autoimmunity: is vitamin D status an environmental factor affecting autoimmune disease prevalence?

Authors:  M T Cantorna
Journal:  Proc Soc Exp Biol Med       Date:  2000-03

Review 10.  The chronobiology of human cytokine production.

Authors:  N Petrovsky; L C Harrison
Journal:  Int Rev Immunol       Date:  1998       Impact factor: 5.311

View more
  24 in total

1.  Serum melatonin level in ankylosing spondylitis: is it increased in active disease?

Authors:  Mohammad Kamal Senna; Shereen Mohamed Olama; Mohammad El-Arman
Journal:  Rheumatol Int       Date:  2011-11-06       Impact factor: 2.631

Review 2.  A review of the multiple actions of melatonin on the immune system.

Authors:  Antonio Carrillo-Vico; Juan M Guerrero; Patricia J Lardone; Russel J Reiter
Journal:  Endocrine       Date:  2005-07       Impact factor: 3.633

Review 3.  The melatonin-cytokine connection in rheumatoid arthritis.

Authors:  M Cutolo; G J M Maestroni
Journal:  Ann Rheum Dis       Date:  2005-08       Impact factor: 19.103

4.  Melatonin treatment does not improve rheumatoid arthritis.

Authors:  Georges J Maestroni; Kati Otsa; Maurizio Cutolo
Journal:  Br J Clin Pharmacol       Date:  2008-02-20       Impact factor: 4.335

Review 5.  Role of circadian neuroendocrine rhythms in the control of behavior and physiology.

Authors:  Henryk F Urbanski
Journal:  Neuroendocrinology       Date:  2011-04-21       Impact factor: 4.914

Review 6.  [Rheumatism, jet lag and the body clock].

Authors:  G Pongratz; R H Straub
Journal:  Z Rheumatol       Date:  2011-06       Impact factor: 1.372

7.  Morning melatonin serum values do not correlate with disease activity in rheumatoid arthritis: a cross-sectional study.

Authors:  Mozhgan Afkhamizadeh; Maryam Sahebari; Seyyed-Reza Seyyed-Hoseini
Journal:  Rheumatol Int       Date:  2014-02-01       Impact factor: 2.631

8.  Melatonin attenuates clock gene cryptochrome1, which may aggravate mouse anti-type II collagen antibody-induced arthritis.

Authors:  Jihye Bang; Hyuk Won Chang; Hae-Ra Jung; Chul-Hyun Cho; Ji-An Hur; Sang-Il Lee; Tae Hyun Choi; Sang-Hyon Kim; Eunyoung Ha
Journal:  Rheumatol Int       Date:  2010-11-28       Impact factor: 2.631

9.  A synthetic peptide derived from A1 module in CRD4 of human TNF receptor-1 inhibits binding and proinflammatory effect of human TNF-alpha.

Authors:  Yingnan Cao; Zhaohe Wang; Xianzhang Bu; Shu Tang; Zhengrong Mei; Peiqing Liu
Journal:  Inflammation       Date:  2009-06       Impact factor: 4.092

Review 10.  Insights into endocrine-immunological disturbances in autoimmunity and their impact on treatment.

Authors:  Maurizio Cutolo; Rainer H Straub
Journal:  Arthritis Res Ther       Date:  2009-04-06       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.